首页> 美国卫生研究院文献>Cell Regulation >Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER–Golgi intermediate compartment
【2h】

Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER–Golgi intermediate compartment

机译:与神经退行性相关的突变TREM2蛋白在ER和ER–Golgi中间区隔之间异常循环

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Triggering receptor expressed on myeloid cells 2 (TREM2) is a transmembrane protein expressed on microglia within the brain. Several rare mutations in TREM2 cause an early-onset form of neurodegeneration when inherited homozygously. Here we investigate how these mutations affect the intracellular transport of TREM2. We find that most pathogenic TREM2 mutant proteins fail to undergo normal maturation in the Golgi complex and show markedly reduced cell-surface expression. Prior research has suggested that two such mutants are retained in the endoplasmic reticulum (ER), but we find, using a cell-free coat protein complex II (COPII) vesicle budding reaction, that mutant TREM2 is exported efficiently from the ER. In addition, mutant TREM2 becomes sensitive to cleavage by endoglycosidase D under conditions that inhibit recycling to the ER, indicating that it normally reaches a post-ER compartment. Maturation-defective TREM2 mutants are also efficiently bound by a lectin that recognizes O-glycans added in the ER–Golgi intermediate compartment (ERGIC) and cis-Golgi cisterna. Finally, mutant TREM2 accumulates in the ERGIC in cells depleted of COPI. These results indicate that efficient ER export is not sufficient to enable normal cell-surface expression of TREM2. Moreover, our findings suggest that the ERGIC may play an underappreciated role as a quality-control center for mutant and/or malformed membrane proteins.
机译:在髓样细胞2(TREM2)上表达的触发受体是在脑内小胶质细胞上表达的跨膜蛋白。当纯合遗传时,TREM2中的几个罕见突变会导致神经变性的早期发作形式。在这里,我们调查这些突变如何影响TREM2的细胞内运输。我们发现大多数致病性TREM2突变蛋白未能在高尔基体中经历正常成熟,并显示出明显降低的细胞表面表达。先前的研究表明,在内质网(ER)中保留了两个这样的突变体,但是我们发现,使用无细胞外壳蛋白复合物II(COPII)囊泡出芽反应,突变体TREM2可从ER有效地输出。另外,突变体TREM2在抑制再循环至ER的条件下变得对糖苷内切酶D的切割敏感,表明其通常到达ER后区室。成熟缺陷型TREM2突变体还被凝集素有效结合,该凝集素可识别ER-高尔基体中间隔室(ERGIC)和顺式-高尔基池中添加的O-聚糖。最后,突变型TREM2在ERPIC中积累在耗尽COPI的细胞中。这些结果表明有效的ER出口不足以使TREM2正常细胞表面表达。此外,我们的研究结果表明,ERGIC作为突变和/或畸形膜蛋白的质量控制中心可能发挥不足的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号